Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T22:53:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, blocking access to the study details. The visible chrome (header/footer) indicates an access restriction rather than actual study content.
    Difference
    19%
    Check dated 2026-09-23T22:43:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Footer now displays the updated software revision from v3.6.6 to v3.7.0. This reflects a platform upgrade rather than any modification to the study data or page content.
    Difference
    0.1%
    Check dated 2026-09-16T22:16:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page was updated from v3.6.5 to v3.6.6, indicating a small website update.
    Difference
    0.1%
    Check dated 2026-09-02T21:53:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.5, indicating a minor platform update. This change does not modify study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-12T09:24:49.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.3 to v3.6.4, reflecting a minor frontend release and updating the page’s version indicator. No substantive study content or functionality is changed.
    Difference
    0.1%
    Check dated 2026-07-21T23:18:07.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.